These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 1719465

  • 21. Structure, biosynthesis and biochemical properties of the HGF receptor in normal and malignant cells.
    Comoglio PM.
    EXS; 1993; 65():131-65. PubMed ID: 8380735
    [Abstract] [Full Text] [Related]

  • 22. Human hepatic myofibroblasts increase invasiveness of hepatocellular carcinoma cells: evidence for a role of hepatocyte growth factor.
    Neaud V, Faouzi S, Guirouilh J, Le Bail B, Balabaud C, Bioulac-Sage P, Rosenbaum J.
    Hepatology; 1997 Dec; 26(6):1458-66. PubMed ID: 9397985
    [Abstract] [Full Text] [Related]

  • 23. Molecular characteristics of HGF-SF and its role in cell motility and invasion.
    Weidner KM, Hartmann G, Naldini L, Comoglio PM, Sachs M, Fonatsch C, Rieder H, Birchmeier W.
    EXS; 1993 Dec; 65():311-28. PubMed ID: 8380739
    [Abstract] [Full Text] [Related]

  • 24. erbB family receptor expression and growth regulation in a newly isolated human breast cancer cell line.
    Ethier SP, Kokeny KE, Ridings JW, Dilts CA.
    Cancer Res; 1996 Feb 15; 56(4):899-907. PubMed ID: 8631031
    [Abstract] [Full Text] [Related]

  • 25. Hepatocyte growth factor (HGF) and receptor (c-met) in normal and malignant astrocytic cells.
    Welch WC, Kornblith PL, Michalopoulos GK, Petersen BE, Beedle A, Gollin SM, Goldfarb RH.
    Anticancer Res; 1999 Feb 15; 19(3A):1635-40. PubMed ID: 10470094
    [Abstract] [Full Text] [Related]

  • 26. Participation of c-met in the progression of human gastric cancers: anti-c-met oligonucleotides inhibit proliferation or invasiveness of gastric cancer cells.
    Kaji M, Yonemura Y, Harada S, Liu X, Terada I, Yamamoto H.
    Cancer Gene Ther; 1996 Feb 15; 3(6):393-404. PubMed ID: 8988842
    [Abstract] [Full Text] [Related]

  • 27. [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma].
    Wu FS, Zheng SS, Wu LJ, Ding W, Ma ZM, Wang ZM, Teng LS, Zhao WH.
    Zhonghua Wai Ke Za Zhi; 2006 May 01; 44(9):603-8. PubMed ID: 16784653
    [Abstract] [Full Text] [Related]

  • 28. The Met/HGF receptor is over-expressed in human osteosarcomas and is activated by either a paracrine or an autocrine circuit.
    Ferracini R, Di Renzo MF, Scotlandi K, Baldini N, Olivero M, Lollini P, Cremona O, Campanacci M, Comoglio PM.
    Oncogene; 1995 Feb 16; 10(4):739-49. PubMed ID: 7862451
    [Abstract] [Full Text] [Related]

  • 29. Lipopolysaccharide potentiates the effect of hepatocyte growth factor upon replication in lung, thyroid, spleen, and colon in rats in vivo.
    Gao C, Kennedy S, Ponder KP.
    Mol Ther; 2001 Apr 16; 3(4):462-75. PubMed ID: 11319906
    [Abstract] [Full Text] [Related]

  • 30. The clinical value of hepatocyte growth factor and its receptor--c-met for liver cancer patients with hepatectomy.
    Wu F, Wu L, Zheng S, Ding W, Teng L, Wang Z, Ma Z, Zhao W.
    Dig Liver Dis; 2006 Jul 16; 38(7):490-7. PubMed ID: 16627020
    [Abstract] [Full Text] [Related]

  • 31. Hepatocyte growth factor and c-met expression in Long-Evans Cinnamon rats with spontaneous hepatitis and hepatoma.
    Nakayama N, Kashiwazaki H, Kobayashi N, Hamada JI, Ogiso Y, Itakura Y, Matsumoto K, Nakamura T, Koike T, Kuzumaki N, Takeichi N.
    Hepatology; 1996 Sep 16; 24(3):596-602. PubMed ID: 8781331
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Identification of a hepatocyte growth factor autocrine loop in a murine mammary carcinoma.
    Rahimi N, Tremblay E, McAdam L, Park M, Schwall R, Elliott B.
    Cell Growth Differ; 1996 Feb 16; 7(2):263-70. PubMed ID: 8822210
    [Abstract] [Full Text] [Related]

  • 34. Insulin-like growth factor I is a comitogen for hepatocyte growth factor in a rat model of hepatocellular carcinoma.
    Price JA, Kovach SJ, Johnson T, Koniaris LG, Cahill PA, Sitzmann JV, McKillop IH.
    Hepatology; 2002 Nov 16; 36(5):1089-97. PubMed ID: 12395318
    [Abstract] [Full Text] [Related]

  • 35. Expression of Met/hepatocyte growth factor receptor gene and malignant behavior of musculoskeletal tumors.
    Scotlandi K, Baldini N, Oliviero M, Di Renzo MF, Martano M, Serra M, Manara MC, Comoglio PM, Ferracini R.
    Am J Pathol; 1996 Oct 16; 149(4):1209-19. PubMed ID: 8863670
    [Abstract] [Full Text] [Related]

  • 36. Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma.
    Kataoka H, Hamasuna R, Itoh H, Kitamura N, Koono M.
    Cancer Res; 2000 Nov 01; 60(21):6148-59. PubMed ID: 11085539
    [Abstract] [Full Text] [Related]

  • 37. The hepatocyte growth factor and its receptor.
    Galimi F, Brizzi MF, Comoglio PM.
    Stem Cells; 1993 Jul 01; 11 Suppl 2():22-30. PubMed ID: 8401259
    [Abstract] [Full Text] [Related]

  • 38. Met protein expression level correlates with survival in patients with late-stage nasopharyngeal carcinoma.
    Qian CN, Guo X, Cao B, Kort EJ, Lee CC, Chen J, Wang LM, Mai WY, Min HQ, Hong MH, Vande Woude GF, Resau JH, Teh BT.
    Cancer Res; 2002 Jan 15; 62(2):589-96. PubMed ID: 11809714
    [Abstract] [Full Text] [Related]

  • 39. Hepatocyte growth factor (HGF/SF) is expressed in human epithelial cells during embryonic development; studies by in situ hybridisation and northern blot analysis.
    Wang Y, Selden C, Farnaud S, Calnan D, Hodgson HJ.
    J Anat; 1994 Dec 15; 185 ( Pt 3)(Pt 3):543-51. PubMed ID: 7649790
    [Abstract] [Full Text] [Related]

  • 40. Expression of hepatocyte growth factor and its receptor c-met proto-oncogene in hepatocellular carcinoma.
    Ueki T, Fujimoto J, Suzuki T, Yamamoto H, Okamoto E.
    Hepatology; 1997 Apr 15; 25(4):862-6. PubMed ID: 9096589
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.